United States · FDA National Drug Code directory
linvoseltamab
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 61755-954_cd897806-909e-4b60-8c31-8ff7218cb9c8
- Product NDC
- 61755-954
- Form
- SOLUTION
- Composition / generic term
- linvoseltamab
- Labeler
- Regeneron Pharmaceuticals, Inc.
- Marketing category
- DRUG FOR FURTHER PROCESSING
- Marketing start / end (source format)
- 20250702
- Source listing expiry
- 20261231
Source-listed ingredients
- LINVOSELTAMAB — 120 g/L
These values do not establish equivalence or a dose recommendation.
Packages
- 1 L in 1 BOTTLE (61755-954-00) · 61755-954-00
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →